Peptide Stacks 2026 — Recovery, Growth Hormone, and Longevity Combinations

Peptide stacking is the practice of combining 2–4 peptides to amplify a clinical effect — most commonly recovery (BPC-157 + TB-500), growth hormone (CJC-1295 + Ipamorelin), or longevity (Epithalon + MOTS-c). Stacking should always be under physician oversight, with attention to cumulative dose and washout periods.

The principle of stacking

Peptide stacking combines 2–4 peptides to amplify a specific clinical effect or to address multiple components of a clinical picture simultaneously. Stacking should always be under physician oversight, with attention to cumulative dose, washout periods, and contraindications.

Recovery stack — BPC-157 + TB-500

The most common stack. BPC-157 250–500 mcg 2× daily + TB-500 2–5 mg weekly, for 4–8 week cycles. Used for major soft-tissue injuries, post-surgical recovery, refractory tendinopathies.

Growth hormone stack — CJC-1295 + Ipamorelin

Most common GH-axis stack. CJC-1295 200–300 mcg + Ipamorelin 200–300 mcg, nightly subcutaneous, 5 on / 2 off. Used for adult GH-decline support, lean-mass preservation during weight loss, sleep architecture support.

Longevity stack — Epithalon + MOTS-c

Epithalon 5–10 mg daily for 10–20 day cycles 1–2× yearly + MOTS-c 10 mg 3× weekly. Used for systemic longevity protocols. Smaller evidence base than the recovery or GH stacks.

Sexual health stack — PT-141 + Kisspeptin

PT-141 on-demand + kisspeptin under specific protocols. Less commonly used; reserved for refractory patients under specialist oversight.

Cycle structure and washout

Most stacks use 4–12 week active cycles followed by 2–8 week washouts. Continuous dosing can produce receptor downregulation and reduces long-term efficacy. Washout periods allow receptor sensitivity to reset.

NexLife approach

NexLife's peptide therapy program at $119/mo covers individualized stacking protocols under physician oversight by Medical Director Adam Kennah, M.D.. Stacks are tailored to patient indication, not prescribed off the shelf.

Sources

• Sigalos JT et al., Growth hormone secretagogues — Sex Med Rev 2018
• BPC-157 / TB-500 review literature — Vukojevic et al.
• Khavinson VK et al., Epithalon — Bull Exp Biol Med